Cargando…
Adjuvant Inhaled Corticosteroids in Community-Acquired Pneumonia: A Review Article
Community-acquired pneumonia is still a major cause of morbidity and mortality worldwide. Since the inflammatory response induced by the immune system is often a major contributor to the lung injury, it becomes reasonable to assess the potential benefit of anti-inflammatory agents in treating commun...
Autores principales: | Kukhon, Faeq R., Festic, Emir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162532/ https://www.ncbi.nlm.nih.gov/pubmed/34071031 http://dx.doi.org/10.3390/medsci9020034 |
Ejemplares similares
-
Inhaled Corticosteroids Is Not Associated with the Risk of Pneumonia in Asthma
por: Lee, Ye Jin, et al.
Publicado: (2023) -
Corticosteroids for community-acquired pneumonia: time to act!
por: Annane, Djillali, et al.
Publicado: (2008) -
Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012) -
Arguments Against Corticosteroids in Community Acquired Pneumonia
por: de Castro, Felipe Rodríguez, et al.
Publicado: (2011) -
The role of corticosteroids in severe community-acquired pneumonia: a systematic review
por: Salluh, Jorge IF, et al.
Publicado: (2008)